Glioblastoma incident studies from May 2006 to May 2007 in Angers and Nice, France;Études des glioblastomes incidents de mai 2006 à mai 2007, Angers-Nice

Neurochirurgie

Volumn 56, Issue 6, 2010, Pages 499-502

  Delion, M ^a   Moraru, C ^a   Almayrac, F ^c   Von Langsdorff, D ^c   Paquis, P ^c   Menei, P ^a,b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c PASTEUR HOSPITAL   (France)

Author keywords

Glioblastoma; Retrospective study

Indexed keywords

TEMOZOLOMIDE;

ARTICLE; AWARENESS; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; FRANCE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; NEUROSURGEON; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREND STUDY; ADULT; AGED; BRAIN TUMOR; CLINICAL TRIAL; FEMALE; MALE; MIDDLE AGED; MULTICENTER STUDY; TIME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; FRANCE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 79953325982     PISSN: 00283770     EISSN: 17730619     Source Type: Journal    
DOI: 10.1016/j.neuchi.2010.07.006     Document Type: Article

References (5)

1. Bauchet L., Mathieu-Daudé H., Fabbro-Peray P., Rigau V., Fabbro M., Chinot O., et al. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro Oncol 2010, (Epub ahead of print). http://www.ncbi.nlm.nih.gov/pubmed/20364023.
2. WHO classification of tumours of the central nerousd system 2007, IARC, Lyon. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee (Eds.).
3. Menei P., Metellus P., Parot-Schinkel E., Loiseau H., Capelle L., Jacquet G., Guyotat J. Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience. Ann Surg Oncol 2010, 17(7):1740-1746. Neuro-oncology Club of the French Society of Neurosurgery.
4. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352(10):987-996.
5. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., et al. Effects of radiotherapy withconcomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10(5):459-466.